Gov. Jerry Brown vetoed a bill supported by Thousand Oaks-based Amgen and other biotechnology companies that would have made it more difficult for pharmacists to dispense so-called biosimilars, the biotech industry’s analogue to generic pharmaceuticals.
Senate Bill 598, approved by both houses of the legislature, looked mostly like a procedural change to state’s pharmacy laws. If it passed, the bill would have allowed pharmacists to fill prescriptions with biosimilars that the U.S. Food and Drug Administration deems “interchangeable” with brand-name counterparts.
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Incoming Amgen chief Robert Bradway takes the baton from longtime CEO Kevin Sharer as the world’s largest biotech company makes critical decisions about how it will compete with Big Pharma and biosimilars. Amgen, the Tri-Counties’ only blue-chip stock and the largest employer in the region with more than 6,000 employees, will install Bradway, a former Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
[wikichart align=”right” ticker=”NASDAQ:AMGN” showannotations=”true” livequote=”true” startdate=”19-04-2011″ enddate=”19-10-2011″ width=”300″ height=”245″] Thousand Oaks-based Amgen is laying off 226 people at its headquarters as part of a restructuring of its research operations. Worldwide, the R&D shakeup will affect 380 staff members, but the company’s headquarters are bearing the brunt of the cuts. The company said the layoffs are Read More →
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.